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THE PROTECTIVE ACTION OF PICROTOXIN IN 
PROLONGED SURGICAL ANESTHESIA WITH EVIPAL*
A .  H . M a l o n e y , p h .d ., m .d .
Professor and Head, Department of Pharmacology and Consultant in Pharmacology at Freedmen’s Hospital
WASHINGTON, D. C.
EVIPAL soluble, the sodium salt of n-methyl-cyclohexenyl-methyl mal- onyl urea, is one of the newer 
barbiturates characterized by a powerful 
hypnotic and anesthetic index associated 
with a remarkably rapid rate of destruction 
in the system when administered parenter- 
ally. This latter characteristic accounts for 
its rather low toxicity as compared with 
other short acting barbiturates like nem­
butal, pernocton and phanodorn.
With respect to its therapeutic index 
Killian1 reported a toxic-narcotic ratio of 
100:24-27 in rabbits; Weese2 a toxic- 
narcotic ratio of 100:25 in cats and 100:30 
in dogs; Kennedy3 a toxic-anesthetic ratio 
of 100:25-32 intraperitoneally in mice 
and rats; Maloney and Hertz4 a toxic- 
anesthetic-hypnotic ratio of 100:36:18  
in rats and approximately 100:24:20 in 
rabbits, both intraperitoneally; Gwathmey5 
a toxic-anesthetic ratio of 100:33, intra­
peritoneally, in dogs, and Storm6 a toxic- 
narcotic ratio of 100:15, intraperitoneally, 
in monkeys.
With respect to its destruction Killian1 
has found that the rabbit detoxifies twice 
the minimal narcotic dose in thirteen 
minutes, while Halberkann7 has indicated 
that evipal, in contradistinction to other 
barbiturates, is almost wholly destroyed 
(97 per cent) in the organism. He was able 
to recover only 2.8 per cent (average) in the 
urine of dogs. In the rapidity with which it 
is disposed by the body evipal bears close 
resemblance to the gaseous anesthetics, 
state Coryllos and Bass.8 In the speed of its 
dynamic effects it surpasses them.
Here is an anesthetic agent exhibiting 
a remarkable pharmacodynamic activity
which is so quickly detoxified by the 
defense mechanisms of the body that, with 
due care as to the rate of injection, several 
doses far in excess of the safety expectancy 
of a single injection may be successfully 
employed. In a previous report on this 
study Maloney and Hertz4 recorded this 
pertinent observation:
The hazard of toxicity is inherent not in 
the drug per se but rather in its absorption 
constant in the system in any unit of time. The 
detoxifying mechanism can cope adequately 
with a vast quantity of the compound spread 
over a relatively long period of time whereas it 
may easily be overwhelmed by a mere fraction 
of that same amount if absorbed in a moment. 
. . . Safety and therapeutic efficiency are con­
sequently functions of rate and degree of 
absorption.
Having had considerable laboratory ex­
perience with picrotoxin administered be­
fore, combined with, and following the 
administration of lethal doses of other 
barbiturates, we treated a case of respira­
tory embarrassment which occurred early 
in the course of our animal experimentation 
with evipal in prolonged anesthesia. The 
counteracting action of picrotoxin in this 
case was so effective that it suggested the 
feasibility of the employment of picrotoxin 
as a routine prophylactic measure.9 Using 
this technique in numerous laboratory 
experiments the fact was established that 
whereas picrotoxin has no inhibitory or 
retarding effect on the anesthetic action of 
evipal it effectively prevents the possibility 
of respiratory paralysis. Since the danger 
in the intravenous administration of evipal 
for purposes of anesthesia lies in its possible 
assault on the respiratory center it follows
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logically that the antecedent protection of 
this center against such impending assault 
is good pharmacological procedure. Picro- 
toxin provides this protection. Conse­
quently all our clinical cases on whom 
evipal is used for prolonged anesthesia 
receive routinely a prophylactic dose of 
picrotoxin.
TECHNIQUE
Selection of Patient. Since evipal is 
detoxified principally, if not entirely, by 
the liver we consider functional impairment 
of this organ the major contraindication. 
Accordingly, a negative Fouchet test is 
done routinely before evipal is selected as 
the anesthetizing agent. In the series of 
cases here reported (Table i) no other 
condition presented itself either as a con­
traindication or complication following its 
use. Mention of other possibilities will be 
made in the discussion.
Preparation of Patient. The patient is 
prepared in the usual manner. When neces­
sary psychic or nervous stabilization on the 
night preceding the operation is obtained 
by the use of morphine-scopolamine, but 
under no circumstances is preanesthetic 
medication allowed. Preliminary sedation 
both complicates the general picture and 
prevents a correct estimation of the effec­
tive anesthetizing dose of evipal. On this 
matter we are in accord with Heard10 and 
Killian.1 Heard says that preoperative 
sedatives should be used with caution; and 
Killian says that their use with evipal is not 
recommended since their depressant action 
combines with the action of evipal and 
impairs respiration.
Induction. Upon signal of readiness 
from the surgeon 2 c.c. of a 0.3 per cent 
solution of picrotoxin is injected intra­
muscularly, the deltoideus being the site 
usually selected. This is followed by an 
immediate enhancement of the rate and 
(or) depth of respiration. The patient is 
then asked to count audibly as soon as the 
needle delivering the evipal solution has 
been inserted into the vein and the injec­
tion has begun. The injection is made fairly
rapidly until the patient’s voice fades 
away. An additional one-third of the dose 
already delivered is then given and the 
injection is stopped, the needle being held 
in the vein. The signal is now given the 
surgeon to begin. Using the same calibre 
syringe and needle at all times the tech­
nician quickly learns to gauge the optimal 
rate of injection. Individual variations 
become a negligible factor with the rapidly 
acquired experience. Because of the relative 
length of the systemic circulation in man 
as compared with small laboratory animals 
the rate of injection in man has to be 
correspondingly increased in order to 
produce anesthesia, so rapidly is the drug 
detoxified. Undue slowness of injection 
rate serves to retard the induction time as 
well as boost the initial amount of the 
anesthetic. The average induction time is 
twenty to thirty seconds. The presence of 
picrotoxin in the system acts as a virtual 
buffer against untoward embarrassment. 
Respiratory accidents are reduced to the 
vanishing point with the employment of 
this technique.
ANALYSIS OF CASES
Blood Pressure. The blood pressure is 
recorded prior to the administration of 
picrotoxin. Whenever possible the sphyg­
momanometer is kept on the arm in which 
event the pressure is recorded at intervals 
of five minutes throughout the operation. 
In every case the pulse and respiration 
rates are taken at five minute intervals. 
There is usually an insignificant initial fall 
of pressure, but this tends to right itself. 
In our cases the drop was merely 2 to 10 
mm. In 2 instances an actual rise in the 
systolic pressure occurred (150 to 170 and 
126 to 130). Two cases exhibiting hyper­
tension showed marked drops (240 to 200 
and 160 to 88). In one patient, twenty-five 
years of age, a pressure of 138 dropped^to 
92. The average systolic pressures at the 
beginning and end of the operation for the 
series were 133 mm. and 118 mm. respec­
tively, constituting an average fall of 
approximately 15 mm. We have taken a
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fall of 30 mm. in an initially normal pres­
sure reading as one indication for a 
supportive dose of picrotoxin.
Pulse. As a rule the pulse rate tends to 
increase during the course of the operation. 
Ten cases in our series manifested slight 
decreases comparing the rates at the end 
with those at the beginning. The average 
pulse rates per minute at the beginning and 
end were 105 and 116  (10 per cent). 
Changes in the rate are of minor significance 
as compared with associated changes in the 
quality of the pulse. Any sign of threadi­
ness or weakening in the course of an 
operation is construed as another indication 
for a supportive dose of picrotoxin.
Respiration. The rate of respiration also 
tends to increase but like the pulse the 
increase is not marked. Five showed slight 
decreases (26-24, 24-18, 36-25, 40-32, 
48-40). Three showed considerable in­
creases at the end over the initial rate 
(22-56, 20-68, 22-68). The majority (78 
per cent) showed slight increases. The 
average increase was 8 per minute, from 
29 at the beginning to 37 at the end of 
operation.
Under evipal anesthesia the respiration 
closely simulates physiological sleep usually 
exhibiting a gentle stertor with a definite 
rhythmicity and depth. We take the 
quality of the respiration as our cardinal 
sign, either withholding the evipal adminis­
tration or gauging the fractional doses ac­
cording to the minutest detectable changes 
of rhythm or depth. In this way a smooth 
course of anesthesia is maintained. Our 
fractional doses, therefore, are character­
ized more by smallness and frequency than 
by quantity. In this connection it is 
pertinent to state that impairment of 
rhythm and depth may result from obstruc­
tion of the air passage. Unless it causes 
gagging the mechanical Cornell airway is 
used routinely. We have had no cases in 
which apnea, hyperpnea, asphyxia or shock 
was observed, or anxiety exhibited by 
surgeon or anesthetist. In no case did any 
untoward condition arise remotely suggest­
ing an emergency calling for the use of
oxygen-carbon dioxide or any other respira­
tory stimulant.
Quality of Anesthesia and Relaxation. 
Care was taken after each operation to have 
the surgeon express in writing his impres­
sions regarding the quality of the anesthesia 
and the nature of the relaxation of skeletal 
muscle and abdominal viscera. These 
impressions are recorded in the table.
Postoperative Notations. The records 
reveal one case developing 4‘ pleuritic 
pains”  on the fourth postoperative day and 
one a “ hypostatic or bronchial pneu­
monia”  on the second day. Both cases 
cleared following digitalis medication. The 
anesthetic, in our opinion, had no causal 
connection with either condition. There 
have been no instances of postoperative 
gastric distress, intestinal distention or 
malaise. The strict withholding of ferment­
able or gas-producing foods and drinks may 
probably have played a beneficial role. The 
most clamant postoperative disturbance in 
our records is what is variously described 
as restlessness, irritability, hyperexcitabil­
ity, and tremors. For the first case where 
restlessness was observed postoperatively 
180 mgm. of nembutal was ordered, as we 
felt that the restlessness was probably due 
to some residue of picrotoxin in the system. 
However, with notices in the literature 
(c./. Heard,10 Coryllos and Bass,8 et al.) of 
such a condition obtaining in which no 
analeptic was administered it was sus­
pected that the anesthetic agent might play 
some role in the production of this hyper­
sensitiveness. We tried morphine with 
unvaryingly good results. A single dose of 
morphine, 10 or 15 mgm., with or without 
atropine has always given the desired seda­
tion; (see also Heard10).
Of the 40 cases presented in this report 
26 or 65 per cent lasted fifty minutes or 
more from the time of incision to the 
making of the last suture. Of these 26, 
18 occupied sixty minutes or more and of 
the 18, 3 lasted 133, 125 and 125 minutes 
respectively; the average duration for the 
series was 58.85 minutes. The average dose 
per person of evipal used throughout the
No.
Patien t
Operation D urationM inutes
*T otaI
E v ip al
G ram s
Blood Pressure
Picrotoxin
during
Operation
R espiration Pulse
Surgeon’ s Com m ents
Postoperative 
O bservations of 
the InternesSex Age W eight Start End Start End Q uality Start End
M arch, 1936
1 F 27 165 C esarean ; sterilization; 
W asserm ann 4-f-
64 210 24 0/14 8 200/140 6 mgm. 40 48 regular 96 132 “ G u t is just as relaxed 
as in spinal anesthe­
s ia ”
J .  W. R oss
R estless— nem butal 180 
m gm .; uneventfu l re­
covery
2 F 21 1 1 5 Cesarean section with 
sterilization
50 2 . 68 120/80 112 / 8 0 None 32 40 regular 1 10 144 “ Anesthesia and relax­
ation good”
J .  W. Ross
500 c.c. 5 per cent glu­
cose during operation, 
1000 c.c. 10  per cent 
glucose after opera­
tion; good recovery; 
d ischarged sixteenth 
postoperative day
3 F 40 2 10 Cesarean section; ster­
ilization; para 1 1 ,  p la­
centa previa
60 2 7 130 /8 0 120/80 12  mgm. 44 regular 120 120 “ Good relaxatio n ”
J .  W. Ross
Restless on aw akening; 
morphine 15  m gm .; 
uneventfu l recovery
4 F 21 138 Cesarean section 50 2.610 114 /6 6 N one “ Silent abdom en”
J .  W. Ross
U neventfu l recovery
5 F 40 165 Sterilization— para 13 , 
glom erulonephritis
40 i . 66 18 0 /10 0 166/94 None 22 56 jerky— regular 84 1 1 2 “ G u t as silent as with 
spinal anesthesia”
J .  W. Ross
Slight restlessness; un­
eventfu l recovery
6 F 23 135 Cesarean section 47 211 140/90 130/9 0 None 30 30 regular 120 108 “ Anesthesia excellen t”  
J .  W. R oss
V ery  restless; m orphine 
15  m gm ., recovery un­
eventfu l
7 F 20 124 Excision o f hip joint, 
tuberculosis of hip
63 1 .6 8 118 /6 0 116 /6 8 None 20 28 regular 148 1 14 “ Q uality perfect; re­
laxation fa ir ”
P. T . Johnson
R ecovery  uneventful
A pril, 1936
8 F 53 145 Open reduction o f frac­
ture of humerus
69 1 • 56 N ot
taken
None 26 24 regular 120 125 “ Q uality and relaxa­
tion good”
P. T . Johnson
Quiet; uneventfu l
9 F 24 1 1 5 C esarean section w ith 
sterilization
9i 2 .4 14 130/80 100/70 None 45 48' regular 100 120 “ Anesthesia gave good 
relaxation of intes­
tines and abdom inal 
m uscles”
J .  W. Ross
V ery  restless 7 hours 
po stoperatively; mor­
phine 15  mgm. with 
atropine 0.5 mgm.
10 M 39 165 Open reduction right 
tib ia ; intram edullary 
graft
87 2 . I» 130/80 1 16 / 7 8 6 mgm. 36 25 regular 120 72 “ R e l a x a t i o n  g o o d ;  
qu ality  good”
P. T . Johnson
Q uiet; uneventfu l re­
covery
1 1 M 26 160 Com m inuted intercon­
d ylar fracture of right 
humerus
67 2 . 1 10 128/80 None 30 30 regular 84 72 “ R e l a x a t i o n  v e r y  
good”
P. T . Johnson
Quiet; uneventfu l re­
covery
12 F 43 120 A ppendectom y 28 II 130 /8 0 120 /75 None 22 24 regular 1 16 94 “ Com plete relaxation 
of abdom inal w all; 
intestines ve ry  quiet. 
T h e anesthesia was 
perfect”
H . R . Burw ell
Pleuritic pains on 
fourth d ay ; cleared 
up with digitalis. 
R ecovery  com plete, 
uneventfu l
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13 F 38 150 A ppendectom y; m ulti­
ple m yom ectom y; 
right salpingectom y, 
left plastic
133 4 • 710 130 /76 104/66 None 20 40 regular 1 1 2 120 “ R e l a x a t i o n  g o o d ; 
sm ooth anesthesia 
throughout”
J .  W. R oss
R espiration  shallow, 
heart rate 107 , w eak; 
sleep profound. Pic- 
rotoxin 6 mgm. R est­
less after fifth hour. 
M orphine 15  mgm. 
R ecovery  com plete
14 M 20 1 75 A ppendectom y 43 1 .6 5 1 10 /6 4 100/66 3 mgm. 18 28 regular 1 1 2 128 “ R e l a x a t i o n  v e r y  
good”
W. M . Lane
N o postoperative dis­
tention; no excitem ent
15 F 14 1 1 2 A ppendectom y 39 i 5 1 16 /8 0 110 /7 0 None 28 38 fa irly  regular 120 136 “ R elaxation  im m edi­
ate; best tow ards last 
part of operation”
W. M . Lane
N o postoperative dis­
turbance. R ecovery  
uneventfu l
16 F 34 1 1 2 R igh t m astoidectom y 24 1 5 115 / 8 0 110 /7 0 None 24 18 regular 1 16 120 “ A n esth esiavery  good; 
no sign of shock”
H. W. Barnes
N o postoperative ill 
effects; no irritab ility
17 F 25 1 14 A ppendectom y, o va­
rian cyst, right
32 1 .  i 3 138 /6 0 92/62 3 mgm. 20 20 regular 82 120 “ R elaxation  com plete 
six minutes after the 
beginning of anesthe­
s ia ”
W. H. W elch
N o sign o f irritab ility ; 
no postoperative dis­
com fort
18 F 47 180 H erniorrhaphy 60 1 . 4 7 16 4 /10 0 15 4 / 10 0 None 18 20 regular 60 84 “ T h e gut is ju st as flat 
as in spinal anesthe­
s ia ”
A. M . Curtis
D eveloped hypostatic 
or bronchial pneu­
monia second day 
postoperative. D ig ita ­
lis and m orphine 
cleared it up in three 
days. Good healing
19 M 20 165 A ppendectom y 50 1.67 130 /76 120/70 None 20 20 regular 78 84 “ In the first part of 
operation intestines 
were pushed out be­
cause of im paired res­
piration. T ongue had 
occluded the respira­
to ry  passage. A fter 
tongue was pulled out 
relaxation was com ­
p lete”
W. M . Lane
P ostoperatively  patient 
is in excellent condi­
tion
20 F 16 1 1 5 L aparo to m y; explora­
to ry
42 1 -35 123/8 0 98/60 None 44 40 regular 96 108 ‘ ‘ Relaxation good; 
qu ality  of anesthesia 
good”
H. R . B urw ell
V ery  restless; morphine 
15  mgm. atropine 1 
mg. N o vom iting; no 
distention; no com­
plications
21 F 18 136 A ppendectom y 55 1 .8 H 78/58 68/50 None 40 48 regular 1 18 120 “  Excellen t anesthesia”  
H. R . Burw ell
Som ew hat irritab le ; no 
vom iting; good post­
operative condition
22 F 28 1 18 L aparotom y 70 1 -55 16 0 /10 0 88/72 3 mgm. 30 30 regular 84 60 “ G o o d  r e l a x a t i o n  
throughout; very  good 
anesthesia”
H. R . Burw ell
N o postoperative dis­
turbances. R ecovery  
com plete
23 F 34 125 D ilatation  o f rectal 
stricture; lym pho­
granulom a inguinale
30 1 • 36 138 /9 0 1 10 / 7 4 None 32 32 regular 120 120 “ R elaxation  splendid; 
qu ality  o f anesthesia 
excellent”
F . Jon es
N o postoperative dis­
turbance. Good con­
dition throughout con­
valescence
* Sm all figure represents num ber o f fractional injections.
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No.
Patien t
Operation D uration
*T otaI
E v ip al
G ram s
Blood Pressure
Picrotoxin
during
O peration
Respiration Pulse
Surgeon’ s Com m ents
Postoperative 
O bservations of 
the InternesSex A ge W eight
M inutes
Start End Start End Q uality Start End
24 F 39 180 A ppendectom y; der­
moid cyst in abdom i­
nal ca v ity
60 1 -75 150/90 102/50 None 44 48 regular 1 1 2 128 “ Anesthesia most satis­
fa c to ry ”
H. R . Burw ell
H yperexcitab le ; m or­
phine and atropine; 
abdom inal distention 
for two days but no 
other com plication
M ay , 1936
2 5 F 25 180 Appendectom y, right 
s a lp in g o -o o p h o re c  t- 
om y,Ieft partialsalp in - 
go-oophorectom y
7i 1 . 96 148/68 130 /6 8 None 24 40 regular 96 136 “ R elaxation  good”
H. R . Burw ell
cn
Sligh tly  restless. R e- c 
covery uneventfu l oq
*«<
26 F 20 1 IO A ppendectom y 39 2§ 1 12 / 7 8 98/72 None 36 36 regular 160 108 “ Anesthesia entirely 
satisfactory ; relaxa­
tion perfect”
W. H. Welch
N o postoperative dis­
com fort
g
27 F 20 120 Decom pression; frac­
ture of left tem poral 
region
45 2 . 27 110 /6 8 110 /7 0 None 26 40 regular 120 150 “ T h is anesthetic seems 
to be ideal for this 
typ e of operation”
A. M . Curtis
Condition good; recov- ^  
ery uneventfu l QP0>f ^
28 F 28 1 18 A ppendectom y, b ilat­
eral oophorectom y
60 24 130 /8 3 108/78 None 40 40 regular 150 140 “ Good relaxatio n ”
W. H. W elch
• •N o postoperative dis­
com fort, rapid con- 1 
valescence ^
29 F 24 120 L y m p h o g r a n u lo m a
inguinale
17 I - 33 15 0 / 10 0 1 7 0 / 1 10 None 48 40 regular 108 164 “ R elaxation  good for 
15  m inutes”
H. R . Burw ell
P atien t com fortable. Q 
N o postoperative dis- O 
turbance
30 F 23 138 B ilateral salpingec­
tom y; appendectom y; 
freeing adhesions
50 2 . I 6 1 10 /9 0 100/78 None 22 30 regular 84 120 “ Anesthesia fine”
W. H. Welch
N o postoperative dis- !_!. 
turbance. Condition £3 
satisfactory  during 
convalescence
3i F 33 180 Cesarean section with 
sterilization
78 I .89 126/80 1 3 0 / 1 IO N one 24 40 Apneic to begin, 
later regular
88 120 “ R elaxation  adeq uate”  
J .  W. Ross
Cam e out of anesthesia 
w ithout restlessness; 
w as unable to void 
urine eighteen hours 
postoperative; cathe- 
terized; recovery un­
eventfu l
32 M 37 160 A m putation of penis 
b y  electrocautery
28 1.85 162/9 2 I 50 /100 None 40 32 regular 84 120 “  Good relaxation ; good 
anesthesia”
R . F . Jon es
N o signs of irritab ility ; 
no vom iting, gradual 
convalescing unevent­
ful recovery
Ju n e, 1936 5?
n
33 F 42 100 A ppendectom y; supra­
vagin al hysterectom y; 
b ilateral salpingo- 
oophorectom y
53 i . 66 16 0 / n o 1 4 0 / 1 IO 3 nigm. 20 68 irregular, jerky  
and shallow
120 140 “ A bdom inal w all and 
intestines well relaxed. 
A nesthesia very  satis­
factory. (R . L . Ja ck - 
son Provident H ospi­
ta l, Baltim ore, M d.) ”
wg
P atien t awoke perfectly  w 
quiet. R ecovery  un-  ^
eventful
0w
ON
A
m
erican
 Jo
u
rn
al o
f Su
rgery 
JV
Ic
lIo
ilC
y
 
P
lC
F
O
tO
X
IIl 
D
e
c
e
m
b
e
r
, 
19
36
34 F 29 130 A ppendectom y; b ilat­
eral salpingectom y; 
b i l a t e r a l  p a r t i a l  
oophorectom y, m yo­
m ectom y
125 3 • o 13 122/9 8 120/80 N one 44 58 regular 124 1 16 “ V ery  good relaxatio n ”  
J .  W. Ross
Postanesthetic recovery 
was good. R estless 
four hours later. From  
this point postopera­
tive course was un­
eventfu l
35 F 47 A ppendectom y; b ilat­
eral oophorectom y; 
hysterectom y
125 3 .0 10 138 /88 12 0 / 18 0 None 22 68 regular 90 100 “ E xcellent relaxation 
smooth anesthesia 
throughout”
J .  W. Ross
Postanesthetic recovery 
good. No restlessness. 
U neventfu l recovery
Ju ly , 1936
36 M 32 150 A ppendectom y 44 I . 2 3 120/70 112/74 None 16 32 regular 80 120 “ R elaxation  good”W. H. Welch H yperexcitab le ; mor­phine; patient states 
anesthesia was very  
good, prefers it to 
ether
37 F 27 147 D ilatation  of rectal 
stricture
95 I . 3 4 120/80 II2 /7 6 None 16 28 regular 84 120 “ Anesthesia good; re­laxation  excellent”
H. R . Burw ell
P atien t im proved pro­
gressively. N o ad­
verse signs
A ugust, 1936
38 F 29 108 Appendectom y, cervi­
cal dilatation curet­
tage; left salpingec­
tom y
50 2.88 106/62 104 /54 None 44 60 regular 90 1 10 “  P erfect relaxation was gotten from anesthe­
s ia ”  (M ercy H ospital, 
Philadelphia, Pa.)
D r. Fortune
Postoperative excite­
m ent was observed. 
Quieted with mor­
phine 15  mgm. R e­
covery uneventful
39 M 11 86 G astrectom y 55 1 .  o3 108 /75 108 /72 None 16 36 regular 80 120 “  Excellent relaxatio n ”  E . Howes P atien t has not experi­enced vom iting nor a 
turn for the worse 
since operation
Septem ber, 1936
40 F 34 135 R epair of vesicovaginal 65 2 . 66 140/80 1 12 / 6 4 None 28 28 regular 120 100 “ A nesthesia all to be desired”
Sligh tly  restless; mor­
phine 10 m gm .; made
fistula
I
J .  W. Ross uneventfu l recovery
* Sm all figure represents number of fractional injections.
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series was 1.875 gm- The largest dose used 
in a single case was 4.7 gm. distributed over 
ten fractional injections, the initial induc­
tion dose being 1 gm. Reference to the 
table will show the variety of operations 
performed.
DISCUSSION
Because of its rapid destruction in the 
system the adaptability of evipal for anes­
thesias of long duration making use of the 
technique of fractional injections p.r.n. 
was soon discovered and adopted.
Rogotzky11 states that it is apparently 
harmless and especially valuable in general 
anesthesia of long duration. Sailer12 and 
Kohlhage13 while especially advocating its 
use both as a basal anesthetic and as a 
general anesthetic for short operations also 
state that it may be used for prolonged 
major operations. Sailer warns of the 
danger of the facile overdose and insists 
that expert induction is as necessary as in 
the case of inhalation anesthesia. Garrey 
and Cohn14 advise the restriction of its 
use to good surgical risks until it has been 
more widely used and better understood. 
Cousineau15 urges that the dosage and the 
rate of injections should be carefully 
watched. Kaminiker and Rintelen16 report 
that while it is employed at the Graz Clinic 
for certain major operations calling for 
fractional injections, its employment for 
orthopedic operations was not approved 
because of the frequent occurrence of motor 
unrest. Beck17 and Baetzner18 encountered 
some trembling and twitching. The former 
attributed this to rapidity of injections, the 
latter to high basal metabolism which 
destroyed the substance so rapidly that 
inadequate dosage probably evoked excita­
tion rather than sleep. He employed sup­
portive amounts of ether or ethyl chloride 
in those cases. Burkle de la Camp19 used it 
for basal, short and long anesthesias with­
out any immediate deleterious results or 
sequela. Ernst20 reports that prolonged 
anesthesia was obtained by fractional doses 
but advises against this because of frequent
changes in the depth of narcosis which is a 
disadvantage alike to surgeon and patient.
By the prophylactic employment of 
picrotoxin, the incidence of respiratory 
embarrassment is effectively offset and 
by the frequency of administration of 
minute fractional doses the desired depth 
and smoothness of anesthesia is easily 
maintained.
Following the recommendation set forth 
by the manufacturers of evipal that the 
dosage should be gauged on the basis of 
0.06 c.c. of a 10 per cent solution per pound 
of body weight with a maximum of 10 c.c. 
(1 gm.) per person, the earlier investigators 
tried to establish a dosimetric scale for 
general use. Heard10 states that the sleep 
inducing dose should be one-half the full 
estimated weight dose. Garrey and Cohn14 
inject 3 to 4 c.c. at the rate of 1 c.c. per 
fifteen seconds leaving the needle in the 
vein for subsequent injections p.r.n. To 
produce anesthesia Sailer12 injects 7 to 
10 c.c. delivering the first 4 c.c. in one 
minute. To prolong anesthesia two-third to 
one-half of the initial anesthetizing dose is 
given. These rules are, however, only of 
suggestive value. Questions of idiosyn­
crasies, age, nutritional state, nervous set 
are always obtrusive. Gorodner21 advises 
that nervous patients require larger and 
debilitated patients relatively smaller doses. 
Cousineau15 reports one death occurring 
two minutes after the injection of 7 c.c. 
Mori22 reports a case of death in three 
minutes of a man seventy-five years of age 
who received 8 c.c. and Kaminiker and 
Rintelen16 report 2 cases of women, seventy 
years old, who manifested severe respira­
tory and circulatory disturbances following 
the injection of 7 c.c. each. Both died; one 
within nine hours and the other three days. 
Mori used his observation to stress the 
warning that schematic dosage according 
to body weight may result in overdosage. 
Kaminiker and Rintelen believe that their 
deaths were not due directly to the narcotic. 
Harms23 advises that the calculated weight 
dosage should be checked by observation of 
objective symptoms during injection so as
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to control factors of possible idiosyncrasies. 
Westerborn24 states that young patients 
often needed twice as much as patients 
between sixty and eighty years of age and 
robust patients generally required more 
than anemic or debilitated ones. In our 
experience the method of individualizing 
our patients, using the abolition of speech 
as guide, has proved quite satisfactory. Its 
utter simplicity commends it. We are not in 
position to say whether or not this simple 
method would work satisfactorily without 
the prophylactic use of picrotoxin.
On the question of contraindications to 
the use of evipal there is a unanimity of 
opinion amongst investigators that hepatic 
dysfunction definitely contraindicates the 
employment of this agent. Either by way of 
elucidation or addition, mention has been 
made of marked sepsis by Merritt;25 peri­
tonitis by Kohlhage;13 bronchial asthma 
by Boden;26 cachexia, dehydration and 
certain nose and throat operations by 
Suraci;27 impaired respiration and sub- 
uremic states, by Killian.1 Early bronchiec­
tasis, diabetes, hypertension, endocarditis 
and advanced carcinoma are mentioned by 
Heard10 as complicating factors. Coryllos 
and Bass8 present a comprehensive state­
ment on contraindications with which we 
are in complete accord. They state: “ It is 
(therefore) obvious that morbid conditions 
causing impairment of hepatic functions 
constitute formal contraindications to the 
use of evipal. Such conditions are jaundice 
—whatever the cause, acute toxemias and 
bacteremias, or chronic and prolonged 
suppurations.”
SUMMARY
The adaptability of evipal soluble by 
fractional injections for use in prolonged 
clinical surgical anesthesia because of its 
rapidity of action and detoxification is 
discussed.
The efficacy of picrotoxin as a prophy­
lactic measure to protect the respiratory 
center from untoward or undue assault by 
the barbiturate is advanced.
The technique employed in the produc­
tion and maintenance of good clinica 
surgical anesthesia is described.
Analysis is made, and a table presented, 
of 40 operations performed under prolonged 
evipal anesthesia by the employment of 
this technique.
A brief discussion of the literature 
pertinent to the subject is presented (a) on 
the experiences and impressions of investi­
gators (b) on the problem of schematic 
dosage and gradation of fractional doses 
and (c) on the question of contraindications 
to the use of evipal.
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